Northwestern Mutual Wealth Management
AQST icon

Northwestern Mutual Wealth Management’s Aquestive Therapeutics AQST Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4
Closed -$26 – 4132
2025
Q4 		$26 Buy
+4
New +$25 ﹤0.01% 3936
2025
Q3 		– Sell
-1,200
Closed -$3.97K – 3802
2025
Q2 		$3.97K Buy
+1,200
New +$3.44K ﹤0.01% 3075
2024
Q4 		– Sell
-50
Closed -$249 – 3609
2024
Q3 		$249 Buy
+50
New +$195 ﹤0.01% 3425

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northwestern Mutual Wealth Management's AQST Position: Q1 2026 in Review

Northwestern Mutual Wealth Management sold out of Aquestive Therapeutics (AQST) in Q1 2026, closing a stake of 4 shares — an estimated $26 sold.

Northwestern Mutual Wealth Management first reported a position in AQST in Q3 2024 and held it in 3 quarters. The position peaked at $3.97K in Q2 2025. 180 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • Northwestern Mutual Wealth Management reported no remaining Aquestive Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 4 Aquestive Therapeutics shares in Q1 2026, an estimated $26.
  • Northwestern Mutual Wealth Management first reported a position in Aquestive Therapeutics in Q3 2024 and held it in 3 quarters.
  • Northwestern Mutual Wealth Management's Aquestive Therapeutics position peaked at $3.97K in Q2 2025.
  • 180 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.